T.S. Wiley testified on April 19, 2007 before the Special Committee on Aging at the United States Senate in Washington D.C., presenting her expertise and experience with menopause and bio-identical hormone replacement therapy, and the changing landscape of women’s health in later years, among other research.

Wiley addressed the fact that the Safe Compounding Drug Act of 2007 would severely restrict and possibly deny access to critical medications and give the

Food and Drug Administration the power to:

• Broadly eliminate the availability of many critical, commonly compounded medications that many patients rely on (most especially bio-identical hormones for women).
• Determine when compounded medicines are needed - a decision that has always been and should always be made by doctors.
• Restrict the compounded medications the doctor can prescribe even if he or she determines the need for them.

You may read about or watch the webcast of this testimony at the Senate Committee on Aging Hearing, featuring T.S. Wiley on April 19, 2007 by clicking on the following links:

Webcast: Bioidentical Hormones: Sound Science or Bad Medicine?

Press release: T.S. Wiley Testifies Before the Special Committee on Aging at the US Senate

Written Document: PDF of Testimony